CONTACT INFORMATION
Eric Herrera
713-862-2505, ext. 23
eric@frog-dog.com

$2 Million in Investments Fuel Growth for Sightline Health

Long-term goals include geographic and technological expansion.

HOUSTON, May 29, 2007—SightLine Health, a health care services company that brings patients access to emerging technology, has secured an additional $2 million in financing.

“As our MR-guided focused ultrasound ablation (MRgFUS) clinics become well established in key markets, we are looking toward broader geographic expansion,” said TJ Farnsworth, the chairman and CEO of SightLine. “Long-term, we also will explore ways to make other new technologies available to patients who need them. This latest round of financing illustrates investor confidence in SightLine’s vision and its team.”

Atlantic Health Group, a privately held health care facility development and management firm, invested $1.75 million, while the remaining $250,000 came from an individual investor.

“SightLine represents a convergence of two trends transforming health care delivery: innovative technology and outpatient accessibility,” said Atlantic’s chief executive officer Jerry Mee. “Health care today is being shaped by effective, noninvasive procedures that can be performed conveniently outside the hospital setting and that enable patients to return to normal activities quickly. Our backing of SightLine, therefore, is an investment in the future of health care.”

To date, SightLine has established some of the nation’s first clinics providing MRgFUS, which uses focused ultrasound waves to destroy abnormal tissues. MRgFUS has been approved by the U.S. Food and Drug Administration as a noninvasive, radiation-free treatment for uterine fibroids, the leading cause of the roughly 600,000 hysterectomies performed in the United States each year. Focused ultrasound technology currently is being studied for treating tumors and other illnesses as well.

The company operates clinics in Houston and Dallas, and has plans to open a third facility in Atlanta.

About SightLine Health
Headquartered in Houston, one of the country’s leading medical communities, SightLine currently specializes in MRgFUS treatment for uterine fibroids. SightLine is one of the few centers in the United States that use ExAblate technology, the only FDA-approved MRgFUS equipment. SightLine employs dedicated radiologists and gynecologists with decades of knowledge in female health and MRI technology that is not found in other MRgFUS facilities. For more information on the procedure and on SightLine, visit the company on the Web at www.sightlinehealth.com.

About Atlantic Health Group
Based in Houston, Atlantic Health Group is a privately held health care facility development and management firm. Its professionals bring executive-level experience with Fortune 500 companies and small, entrepreneurial health care organizations. This blend of experience has resulted in a company that operates with exceptional internal controls and exemplifies progressive business practices. For more information on Atlantic Health Group, visit the company on the Web at www.atlantic-health.com.

Back to News